Differential Cytokine Response in Host Defence Mechanisms Triggered by Gram-Negative and Gram-Positive Bacteria, and the Roles of Gabexate Mesilate, a Synthetic Protease Inhibitor von Iwadou, H, Morimoto, Y, Iwagaki, H, Sinoura, S, Chouda, Y, Kodama, M, Yoshioka, T, Saito, S, Yagi, T, Tanaka, N

Volltext

Clinical value of soluble interleukin-2 receptor in infectious complications von Iwagaki, H, Hizuta, A, Iwadou, H, Perdomo, J A, Tanaka, N, Orita, K

Volltext

Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion... von Kudo, M, Ueshima, K, Yokosuka, O, Obi, S, Izumi, N, Aikata, H, Nagano, H, Hatano, E, Sasaki, Y, Hino, K, Kumada, T, Yamamoto, K, Imai, Y, Iwadou, S, Ogawa, C, Okusaka, T, Arai, Y, Kanai, F, Akazawa, K

Volltext

LB04 - Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial I... von Kudo, M., Ueshima, K., Yokosuka, O., Obi, S., Izumi, N., Aikata, H., Nagano, H., Hatano, E., Sasaki, Y., Hino, K., Kumada, T., Yamamoto, K., Imai, Y., Iwadou, S., Ogawa, C., Okusaka, T., Arai, Y., Kanai, F., Akazawa, K.

Volltext

Supplementary Material for: Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS... von Kudo, M., Ueshima, K., Chiba, Y., Ogasawara, S., Obi, S., Izumi, N., Aikata, H., Nagano, H., Hatano, E., Sasaki, Y., Hino, K., Kumada, T., Yamamoto, K., Imai, Y., Iwadou, S., Ogawa, C., Okusaka, T., Kanai, F., Arai, Y.

Volltext bestellen